nad has been researched along with Dementia, Vascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guan, X; Jiang, G; Pang, T; Tang, L; Xie, L; Zhao, N; Zhu, X | 1 |
| Haushofer, M; Jellinger, KA; Kraxberger, E; Mucke, HA; Rainer, M | 1 |
1 trial(s) available for nad and Dementia, Vascular
| Article | Year |
|---|---|
No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Dementia; Dementia, Vascular; Drug Therapy, Combination; Female; Humans; Language; Male; Memory; Mental Status Schedule; Middle Aged; NAD; Orientation; Psychiatric Status Rating Scales; Psychological Tests; Treatment Failure | 2000 |
1 other study(ies) available for nad and Dementia, Vascular
| Article | Year |
|---|---|
The Combination of Citicoline and Nicotinamide Mononucleotide Induces Neurite Outgrowth and Mitigates Vascular Cognitive Impairment via SIRT1/CREB Pathway.
Topics: Animals; Cognitive Dysfunction; Cytidine Diphosphate Choline; Dementia, Vascular; NAD; Neuroinflammatory Diseases; Neuronal Outgrowth; Nicotinamide Mononucleotide; Rats; Sirtuin 1 | 2023 |